New Market Study Published: Iran Pharmaceuticals & Healthcare Report Q4 2013
Iran's pharmaceutical market will become increasingly reliant on pharmaceutical imports over the next decade. In light of ongoing trade sanctions, increasing import reliance puts Iran at significant risk of long-term medicine shortages. Uptake of medicines in the short-term is further risked by currency depreciation and hyperinflation of local medicine prices. We believe the medicines market will contract in 2013, before the return of growth in 2014.
View full press release